Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 289,708
Prepaid expenses and other current asset 628,181
Due from Sponsor 395,000  
Total Current Assets 1,312,889
Deferred offering costs 165,778
Cash and marketable securities held in Trust Account 253,025,092
Total Assets 254,337,981 165,778
Current liabilities    
Accounts payable and accrued expenses 111,259
Accrued offering costs 324,400 140,778
Promissory note — related party 5,000
Total Current Liabilities 435,659 145,778
Warrant Liabilities 31,790,225
Deferred underwriting fee payable 8,855,000
Total Liabilities 41,080,884 145,778
Commitments
Class A ordinary shares subject to possible redemption, 20,823,644 and no shares at redemption value as of June 30, 2021 and December 31, 2020, respectively 208,257,092
Shareholders’ Equity    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding as of June 30, 2021 and December 30, 2020
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 4,476,356 (excluding 20,823,644 and no shares subject to possible redemption) and no shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively 448
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 6,325,000 shares issued and outstanding as of June 30, 2021 and December 31, 2020 633 633
Additional paid-in capital 7,623,373 24,367
Accumulated deficit (2,624,449) (5,000)
Total Shareholders’ Equity 5,000,005 20,000
Total Liabilities and Shareholders’ Equity $ 254,337,981 $ 165,778